AGM Information • May 4, 2023
AGM Information
Open in ViewerOpens in native device viewer


Istrana (TV), May 4, 2023 — Labomar SpA (Ticker: LBM), an Italian-based international nutraceutical enterprise listed on the Euronext Growth Milan market announces that the Shareholders' Meeting of the Company to approve the 2022 Financial Statements of the company was held today, reporting a Net profit of Euro 4,382,105, together with the Directors' Report, in addition to the Annual Report on the pursuit of the common benefit as per the Stability Law 208/2015 ("2022 Impact Report").
The Shareholders' Meeting then approved, on the proposal of the Board of Directors, the allocation of the Net profit and the distribution to shareholders of an ordinary dividend of Euro 0.10 for each of the entitled shares.
The dividend coupon date shall be May 15, 2023, with dividend record date of May 16, 2023 and payout on May 17, 2023.
The Shareholders' Meeting also appointed the new Board of Directors of Labomar Spa, establishing its number of members as 7.
It shall comprise the following members: Walter Bertin, Sabrina Gasparato, Claudio De Nadai, Lorenzo Zambon, Renzo Torchiani, Alberto Baban and Ugo Di Francesco, all from the sole slate filed by the majority shareholder LBM Holding Srl.
The Director Alberto Baban declared his independence in accordance with Article 148, paragraph 3 of Legislative Decree No. 58/1998 and Article 17.1 of the By-Laws, which was positively assessed by the Euronext Growth Advisor of the company as per Article 6bis of the Euronext Growth Milan Issuers' Regulation.
The Shareholders' Meeting also appointed Mr. Walter Bertin as Chairperson of the Board of Directors, setting the total annual remuneration of the Board of Directors in the gross amount of Euro 668,000.
The Chairperson Walter Bertin today, through LBM Holding Srl, holds indirectly 67.3% of Labomar Spa's shares, while the Director Claudio De Nadai personally holds 0.3% of the company share capital.
The Shareholders' Meeting thereafter appointed - on the proposal of the majority Shareholder - also the new Board of Statutory Auditors, comprised as follows: Tiziano Cenedese (Chairperson), Giuseppe Bacchin and Mirko Pozzobon (Statutory Auditors), Lorenzo Fracasso and Alberto Pellizzato (Alternate Auditors).
The Shareholders' Meeting approved the remuneration of the entire Board of Statutory Auditors for each year of mandate as a total gross amount of Euro 28,000, of which Euro 12,000 for the Chairperson of the Board of the Statutory Auditors and Euro 8,000 for each Statutory Auditor.
Both corporate boards shall remain in office for three years, until the Shareholders' Meeting called to approve the financial statements at December 31, 2025.


The Board of Directors of the company, meeting subsequent to the Shareholders' Meeting, confirmed Mr. Walter Bertin as the Chief Executive Officer - granting him powers in line with those existing - and Ms. Sabrina Gasparato as the Vice Chairperson, confirming also the Director Claudio De Nadai as the Investor Relations Manager.
The company announces that copies of the 2022 Financial Statements of Labomar Spa, of the Labomar Group 2022 Consolidated Financial Statements and the Labomar Spa 2022 Impact Report (these latter two in their Italian and English versions) are available at the registered office, in addition to the company website Labomar Spa www.labomar.com, in the "Governance / Shareholders' Meeting" and "Investors / Results and Press Releases" sections.
This press release is published on the platform on the site, in addition to the Labomar Spa website www.labomar.com, in the "Governance / Shareholders' Meeting" and "Investors / Results and Press Releases" sections.
The minutes of the Shareholders' Meeting shall be published in accordance with the applicable regulation, also on the company website www.labomar.com, in the "Governance / Shareholders' Meeting" section.
*****
Founded by Walter Bertin in Istrana (province of Treviso) in 1998, Labomar is specialised in the development and production of food supplements, medical devices, foods for special medical purposes and cosmetics for third parties. Over more than 20 years, Labomar has built a business model which sets it apart from its competitors and generates value for all stakeholders, providing a comprehensive service and a high quality and productivity standard. The company boasts a well-structured and cutting-edge research and development department with a particular focus on innovation, a commercial team which reacts quickly to market demands and a high level of product differentiation thanks to its proprietary patents and formulas.
Following the acquisitions of the Welcare Group and Labiotre Srl, in addition to the establishment of LaboVar Srl, in 2022 Labomar focused on maximising the synergies among the various companies, pooling resources and expertise to expand its product portfolio, enter new markets and streamline certain processes, including through the best practices brought by each of the Group companies.
Labomar whole-heartedly believes in a business system based on sustainability and a real concern for people, the environment and the community. It therefore by 2020 had gained Benefit Company status and simultaneously embarked on obtaining B-Corp Certification, for which it has already applied to the relative body for certification issuance. This is testament to the company's decision to join a global movement of enterprises meeting elevated social and environmental impact standards.
Labomar Press Office Thanai Bernardini - +39.335.7245418 - [email protected] Alessandro Bozzi Valenti - +39.348.0090866 - [email protected] Margherita Bertolo - +39.328.5574976 - [email protected]
Investor Relations Labomar Claudio De Nadai - +39.0422.677203 - [email protected] Mara Di Giorgio - +39 335 7737417 - [email protected]
Euronext Growth Advisor Banca Mediolanum - +39 02 9049 2525 - [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.